Thursday, December 13, 2012

Leimo Offers 1-month Free Hair Loss Treatment Trial Period

Hair loss affects nearly 50% of world’s adult population. Those who suffer from it do not only suffer a drastic change in appearance but also in self-esteem. Being on the mission to provide utmost convenience in at-home hair restoration, Leimo is offering a 1-month free hair loss treatment trial of its amazing range.

Complete with a range of products that stop hair loss, regrow hair, and promote overall hair and scalp health, the Personal Hair Laser Starter Kit is a proof that hair loss doesn’t have to stay forever. This kit includes the Bio Cleansing Shampoo, Thickening Conditioner, Scalp Therapy Day Treatment, Scalp Serum Night Treatment, Scalp & Body Scrub, and the Personal Hair Laser.

    Leimo has shot to fame in Australia for its strategic employment of technology and nature in the field of non-invasive hair restoration. By using Leimo’s organic and plant-based topical treatments and hair care products, hair loss sufferers can prevent further balding caused by DHT while being guaranteed that hair and scalp integrity is restored. Complementing the topical treatments is Leimo’s high-end medical hair laser, which is integrated with top-notch laser technology system design to stimulate new hair growth without any side effects. This synergistic collection ensures only a fuller, stronger, and longer head of hair.

Balding and hair thinning problems can be addressed especially in their early stages. Leimo can provide a professional treatment and hair care to people who seek a safe, organic, and innovative at-home solution. To learn more about the Leimo 30-day free hair loss treatment trial, visit www.leimo.com.au or call 1800-280-250.   

About Leimo International

Leimo International has a vision to be the world’s leading Hair Regrowth solution with an absolute commitment to help our customers achieve hair regrowth naturally in the comforts of their own home. Leimo International is headquartered in Woombye, Queensland.
              

No comments:

Post a Comment